Please enable Javascript
Boris Pasche, MD, PhD
Boris Pasche, MD, PhD
Articles by Boris Pasche, MD, PhD
TheraBionic P1: A New Systemic Targeted Therapy for Advanced HCC
Boris Pasche, MD, PhD
Liver Cancer
|
January 28, 2025
Dr. Pasche discusses the trial that led to the TheraBionic P1 device's regulatory approval by the FDA.
View More